New Launch18 Aug 2025, 03:38 pm
Sai Life Sciences Debuts on BSE, NSE with 20.22% Premium
AI Summary
Sai Life Sciences, a leading life sciences company, made a successful listing on the BSE Limited and the National Stock Exchange of India Limited on December 18, 2024. The company's Initial Public Offering (IPO) was subscribed 10.27 times, with bids for 39.85 Cr shares against 3.87 Cr shares on offer. The offering saw healthy participation across categories, with shares debuting at ₹ 650 on the NSE and ₹ 660 on the BSE, reflecting a premium of 18.4% and 20.22% over the issue price, respectively.
Key Highlights
- Sai Life Sciences made a successful listing on the BSE Limited and the National Stock Exchange of India Limited.
- The company's IPO was subscribed 10.27 times, with bids for 39.85 Cr shares against 3.87 Cr shares on offer.
- Shares debuted at ₹ 650 on the NSE and ₹ 660 on the BSE, reflecting a premium of 18.4% and 20.22% over the issue price, respectively.
- The offering saw healthy participation across categories.
- The listing marks a new chapter for Sai Life Sciences, strengthening the foundation for long-term, science-led growth.